The Phase III trial is set to use growth outcomes as its primary endpoint in the 52-week trial of JR-142, a long-acting growth hormone.

While excessive alcohol consumption has serious health consequences, a new multicentre study provides new evidence that ...

The study was carried out in 1,232 participants in the PREDIMED project, a major scientific epidemiological study in ...

This is needed as the optimal treatment for shoulder pain remains unclear.9 The objective of this multicentre longitudinal cohort study was to identity which patient and clinical characteristics, ...